NASDAQ:INSP - Inspire Medical Systems Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$53.99 +0.70 (+1.31 %)
(As of 05/24/2019 04:00 PM ET)
Previous Close$53.99
Today's Range$53.34 - $54.58
52-Week Range$27.30 - $64.34
Volume133,668 shs
Average Volume331,332 shs
Market Capitalization$1.29 billion
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The company was founded in 2007 and is headquartered in Maple Grove, Minnesota.

Receive INSP News and Ratings via Email

Sign-up to receive the latest news and ratings for INSP and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Medical Devices
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:INSP
CUSIPN/A
PhoneN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

EmployeesN/A
Market Cap$1.29 billion
Next Earnings Date8/6/2019 (Estimated)
OptionableOptionable

Inspire Medical Systems (NASDAQ:INSP) Frequently Asked Questions

What is Inspire Medical Systems' stock symbol?

Inspire Medical Systems trades on the NASDAQ under the ticker symbol "INSP."

How were Inspire Medical Systems' earnings last quarter?

Inspire Medical Systems (NASDAQ:INSP) issued its quarterly earnings results on Tuesday, May, 7th. The company reported ($0.35) EPS for the quarter, topping the consensus estimate of ($0.39) by $0.04. The business had revenue of $16.30 million for the quarter, compared to analyst estimates of $17.79 million. The company's revenue for the quarter was up 63.0% on a year-over-year basis. View Inspire Medical Systems' Earnings History.

When is Inspire Medical Systems' next earnings date?

Inspire Medical Systems is scheduled to release their next quarterly earnings announcement on Tuesday, August 6th 2019. View Earnings Estimates for Inspire Medical Systems.

What guidance has Inspire Medical Systems issued on next quarter's earnings?

Inspire Medical Systems issued an update on its FY 2019 earnings guidance on Tuesday, February, 26th. The company provided EPS guidance of for the period. The company issued revenue guidance of $67-70 million, compared to the consensus revenue estimate of $64.56 million.

What price target have analysts set for INSP?

8 Wall Street analysts have issued 12-month target prices for Inspire Medical Systems' shares. Their predictions range from $25.00 to $64.00. On average, they anticipate Inspire Medical Systems' stock price to reach $41.6250 in the next year. This suggests that the stock has a possible downside of 22.9%. View Analyst Price Targets for Inspire Medical Systems.

What is the consensus analysts' recommendation for Inspire Medical Systems?

8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Inspire Medical Systems in the last year. There are currently 1 sell rating, 2 hold ratings and 5 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Inspire Medical Systems.

Has Inspire Medical Systems been receiving favorable news coverage?

News articles about INSP stock have trended positive this week, according to InfoTrie Sentiment. InfoTrie identifies positive and negative press coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. Inspire Medical Systems earned a media sentiment score of 3.0 on InfoTrie's scale. They also assigned news articles about the company a news buzz of 4.0 out of 10, meaning that recent press coverage is somewhat unlikely to have an impact on the stock's share price in the next several days.

Who are some of Inspire Medical Systems' key competitors?

What other stocks do shareholders of Inspire Medical Systems own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Inspire Medical Systems investors own include Intelsat (I), Bank of America (BAC), Chaarat Gold (CGH), Alibaba Group (BABA), Associated British Foods (ABF), Fossil Group (FOSL), AMC Entertainment (AMC), Ciena (CIEN), First Data (FDC) and Cisco Systems (CSCO).

Who are Inspire Medical Systems' key executives?

Inspire Medical Systems' management team includes the folowing people:
  • Mr. Tim Herbert, Chief Exec. Officer and Pres
  • Mr. Richard Buchholz, Chief Financial Officer
  • Mr. Randy Ban, Sr. VP of Sales and Marketing
  • Mr. Sean Cleary, VP of Global Market Devel.
  • Mr. Gary A. Goetzke, VP of Health Economics

When did Inspire Medical Systems IPO?

(INSP) raised $75 million in an initial public offering on Thursday, May 3rd 2018. The company issued 5,000,000 shares at $14.00-$16.00 per share. BofA Merrill Lynch and Goldman Sachs acted as the underwriters for the IPO and Guggenheim Securities, Stifel and Wells Fargo Securities were co-managers.

Who are Inspire Medical Systems' major shareholders?

Inspire Medical Systems' stock is owned by a variety of of retail and institutional investors. Top institutional investors include Morgan Stanley (5.84%), William Blair Investment Management LLC (4.60%), BlackRock Inc. (4.18%), OppenheimerFunds Inc. (2.22%), KPCB XII Associates LLC (1.69%) and TimesSquare Capital Management LLC (1.55%). Company insiders that own Inspire Medical Systems stock include Amzak Health Investors, Llc, Casey M Tansey, Jerry C Griffin, Joyce Erony, Marilyn C Nelson, Randy Ban, Richard Buchholz, Steven Jandrich and Timothy P Herbert. View Institutional Ownership Trends for Inspire Medical Systems.

Which major investors are selling Inspire Medical Systems stock?

INSP stock was sold by a variety of institutional investors in the last quarter, including KPCB XII Associates LLC, Schonfeld Strategic Advisors LLC, TimesSquare Capital Management LLC, Pier Capital LLC, Pentwater Capital Management LP, Osterweis Capital Management Inc., SEI Investments Co and JPMorgan Chase & Co.. Company insiders that have sold Inspire Medical Systems company stock in the last year include Casey M Tansey, Jerry C Griffin, Joyce Erony, Marilyn C Nelson, Randy Ban, Richard Buchholz and Timothy P Herbert. View Insider Buying and Selling for Inspire Medical Systems.

Which major investors are buying Inspire Medical Systems stock?

INSP stock was acquired by a variety of institutional investors in the last quarter, including Morgan Stanley, William Blair Investment Management LLC, OppenheimerFunds Inc., Dimensional Fund Advisors LP, Columbus Circle Investors, Victory Capital Management Inc., BlackRock Inc. and Spark Investment Management LLC. Company insiders that have bought Inspire Medical Systems stock in the last two years include Amzak Health Investors, Llc, Marilyn C Nelson, Randy Ban, Richard Buchholz, Steven Jandrich and Timothy P Herbert. View Insider Buying and Selling for Inspire Medical Systems.

How do I buy shares of Inspire Medical Systems?

Shares of INSP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Inspire Medical Systems' stock price today?

One share of INSP stock can currently be purchased for approximately $53.99.

How big of a company is Inspire Medical Systems?

Inspire Medical Systems has a market capitalization of $1.29 billion.

What is Inspire Medical Systems' official website?

The official website for Inspire Medical Systems is http://www.inspiresleep.com/.


MarketBeat Community Rating for Inspire Medical Systems (NASDAQ INSP)

Community Ranking:  2.1 out of 5 (star star)
Outperform Votes:  56 (Thanks for Voting!)
Underperform Votes:  75 (Thanks for Voting!)
Total Votes:  131
MarketBeat's community ratings are surveys of what our community members think about Inspire Medical Systems and other stocks. Vote "Outperform" if you believe INSP will outperform the S&P 500 over the long term. Vote "Underperform" if you believe INSP will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 5/25/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel